|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 279, Issue 30, 31171-31176, July 23, 2004
Identification and Characterization of the DNA-binding Domain of the Multifunctional PutA Flavoenzyme*![]() ![]() || **![]() ![]() ¶![]() ![]()
From the
Received for publication, April 2, 2004 , and in revised form, May 17, 2004.
The PutA flavoprotein from Escherichia coli is a transcriptional repressor and a bifunctional enzyme that regulates and catalyzes proline oxidation. PutA represses transcription of genes putA and putP by binding to the control DNA region of the put regulon. The objective of this study is to define and characterize the DNA binding domain of PutA. The DNA binding activity of PutA, a 1320 amino acid polypeptide, has been localized to N-terminal residues 1261. After exploring a potential DNA-binding region and an N-terminal deletion mutant of PutA, residues 190 (PutA90) were determined to contain DNA binding activity and stabilize the dimeric structure of PutA. Cell-based transcriptional assays demonstrate that PutA90 functions as a transcriptional repressor in vivo. The dissociation constant of PutA90 with the put control DNA was estimated to be 110 nM, which is slightly higher than that of the PutA-DNA complex (Kd 45 nM). Primary and secondary structure analysis of PutA90 suggested the presence of a ribbon-helix-helix DNA binding motif in residues 147. To test this prediction, we purified and characterized PutA47. PutA47 is shown to purify as an apparent dimer, to exhibit in vivo transcriptional activity, and to bind specifically to the put control DNA. In gel-mobility shift assays, PutA47 was observed to bind cooperatively to the put control DNA with an overall dissociation constant of 15 nM for the PutA47-DNA complex. Thus, N-terminal residues 147 are critical for DNA-binding and the dimeric structure of PutA. These results are consistent with the ribbon-helix-helix family of transcription factors.
Proline utilization A (PutA) from Escherichia coli is a multifunctional enzyme that catalyzes the flavin-dependent oxidation of proline to 1-pyrroline-5-carboxylate (P5C)1 and the NAD-dependent oxidation of P5C to glutamate (1, 2). In the dehydrogenation of proline to P5C, two electrons are transferred from proline to a non-covalently bound FAD. Electrons from reduced FAD are then transferred to an acceptor in the electron transport chain to complete the catalytic cycle (3). Next, P5C, the product of the first reaction, is hydrolyzed to glutamate- -semialdehyde followed by subsequent transfer of two electrons to an NAD+ cofactor by the P5C dehydrogenase domain to yield glutamate. In addition to enzymatic roles in proline utilization, PutA is responsible for the transcriptional regulation of the proline utilization genes putA and putP (1, 48). PutP encodes a high affinity sodium-proline transporter (9). PutA represses the expression of the put genes, which are transcribed in opposite directions, by binding to the put intergenic DNA region (1, 7, 8). The transcriptional repression of the put genes is relieved in the presence of proline by the translocation of PutA to a peripheral position on the membrane, where proline is efficiently converted to glutamate. Reduction of the flavin causes a conformational change in PutA that is thought to enhance PutA membrane associations, thereby disrupting PutA-DNA binding (8, 10, 11).
Insights into the organization of the functional domains in PutA have been gained from molecular dissection and characterization of truncated PutA proteins. PutA is a polypeptide of 1320 amino acids and purifies predominately as a dimer, although minor amounts of monomer species are observed. The dimeric form of PutA has an estimated molecular mass of The goal of this study was to identify and characterize the DNA-binding domain of PutA. By engineering and examining several truncation and site-directed PutA mutants, we have identified the DNA-binding domain of PutA. In this report, we establish that N-terminal residues 147 comprise a domain that is responsible for the DNA binding activity of PutA. It is surprising that N-terminal residues 147 are also essential for dimerization of PutA, suggesting that this region is a key element for the versatility of PutA. The properties of the isolated DNA-binding domain (PutA47) are described and suggest that PutA is a member of the ribbon-helix-helix (RHH) family of DNA binding proteins. The implications of these findings are discussed in terms of the multifunctional properties of PutA.
MaterialsAll chemicals and buffers were purchased from Fisher Scientific and Sigma-Aldrich, Inc. Restriction endonucleases and T4 DNA ligase were purchased from Fermentas and Promega, respectively. Molecular size standards used for calibrating size exclusion columns were purchased from Sigma. BCA reagents used for protein quantitation were obtained from Pierce. All experiments used Nano-pure water. E. coli strains XL-Blue and BL21 DE3 pLysS were purchased from Novagen. E. coli strain JT31 putA lacZ was a generous gift from J. Wood (University of Guelph, Guelph, ON, Canada). The vector pET-23b (Novagen) containing a hexahistidine-encoded sequence was used for expression of PutA669 R230/R234, PutA 85, and PutA261 as C-terminal hexahistidine-tagged proteins. The vector pET-14b was used for the expression of PutA139258 as an N-terminal hexahistidine-tagged protein. The vector pET-3a (Novagen) was used for the expression of PutA90 and PutA47, which results in the addition of a GSGC amino acid sequence at the C-terminal end. Sequence-specific synthetic oligonucleotides were purchased from Integrated DNA Technologies. The put intergenic DNA (419 bp) used for DNA binding assays was prepared as described previously using genomic DNA from E. coli strain JT31 (14).
Preparation of PutA Protein and Reporter ConstructsA PutA
A reporter construct containing the lacZ gene (3.5 kb) under control of the put regulatory region (putC, 419 bp) was prepared as a derivative of pACYC184 (New England Biolabs). The lacZ gene, obtained from a PROTet.333 vector (Clontech), was positioned downstream of the put control DNA region in pUTC01 (a pUC18 vector containing the put intergenic DNA sequence, putC) using PstI and SalI to generate pUTC02 (14). A partial digest of pUTC02 with PstI and EcoRI generated a 3.9-kb fragment that contained putC and the lacZ gene (putC: lacZ). The 3.9-kb fragment was inserted into pACYC184 using PstI and EcoRI, resulting in a low copy construct containing the lacZ reporter gene under control of the put control DNA (pUTC03). Constructs to test in vivo transcriptional repressor activity of PutA, PutA
Purification and Characterization of PutA ProteinsPutA669 mutant R230A/R234, PutA PutA90 and PutA47 were also overexpressed in E. coli strain BL21 DE3 pLysS at 37 °C as described previously but without a hexahistidine tag (13). PutA90 was purified by anion exchange chromatography as described for PutA (14). Eluted PutA90 was identified by SDS-PAGE (15%) analysis and gel-mobility shift assays. PutA90 was then applied to a heparin column (Sigma) equilibrated with 10 mM Tris-HCl, pH 7.58.0, and eluted in the same buffer containing 1.5 M NaCl. Fractions containing PutA90 were identified by SDS-PAGE analysis and dialyzed into 50 mM Tris, pH 7.5, containing 10% glycerol. Because the isoelectric point for the PutA47 denatured polypeptide is around pH 7.9, PutA47 was purified using cation exchange chromatography. PutA47 cell supernatant was applied to a CM-Sepharose column (Sigma) equilibrated with 20 mM MES, pH 6.5, containing 5% glycerol. A 1-liter gradient from 0 to 500 mM NaCl in 20 mM MES, pH 6.5, and 5% glycerol eluted PutA47. Fractions containing PutA47 were identified by SDS-PAGE (18%) and gel-mobility shift assays. PutA47 was then concentrated using a 50-ml Amicon ultrafiltration cell with a 10-kDa molecular mass cutoff and purified further by gel-filtration using a Superdex-75 column (Amersham Biosciences) equilibrated with 50 mM Tris, pH 7.5. Purified PutA90 and PutA47 were stored in 50 mM Tris, pH 7.5, containing 10% glycerol at 70 °C.
The concentrations of the PutA proteins were determined using the BCA method (Pierce) with bovine serum albumin as the standard and spectrophotometrically using a molar extinction coefficient at 451 nm of 12,800 M1 cm1 for PutA669 mutant R230/R234 and PutA
The molecular sizes of PutA
DNA Binding AssaysNondenaturing gel electrophoretic mobility shift assays were used to test the binding of the PutA proteins to the put control intergenic DNA as described previously (14). The overall dissociation constant (Kd) of PutA90 with the put intergenic DNA was estimated from nitrocellulose filter binding assays. The put intergenic DNA was labeled at the 5' end with [ In gel-shift assays with PutA47, fluorescently labeled put intergenic DNA was used in the binding reactions. The synthetic oligonucleotide 5' end-labeled with IRdye-700 (LI-COR, Inc.) was used as one of the primers in a PCR reaction to amplify the put intergenic DNA. The resulting IRdye-700 labeled put intergenic DNA was purified and quantitated by measuring the nucleic acid concentration at 260 nm and the absorbance of the IRdye-700 at 685 nm using an extinction coefficient of 170 mM1 cm1 according to the recommendations of the manufacturer. PutA47 (0200 nM) was incubated with 2 nM put intergenic DNA in a total volume of 25 µl in 50 mM Tris, pH 7.5, containing 10% glycerol for 20 min before electrophoresis. Calf thymus competitor DNA (100 µg/ml) was added to the binding mixtures to prevent nonspecific PutA47-DNA interactions. The PutA47-DNA complexes were separated using a polyacrylamide (8%) native gel at 4 °C. The gels were visualized and the fraction of DNA bound was determined using a LI-COR Odyssey Imager. Data from three independent binding experiments were averaged and analyzed using the equation above.
LacZ Reporter AssaysE. coli strain JT31 putA lacZ containing putC:lacZ (pUT03) and various putA gene constructs (pUC18-PutA) were grown at 37 °C in minimal medium with ampicillin (50 µg/ml) and chloramphenicol (30 µg/ml) to OD at 600 nm
Localization of DNA-binding to the N-terminal RegionA potential HTH motif was identified from the PutA669 x-ray crystal structure involving residues 139258 (13). A truncated PutA protein that contains the HTH motif (PutA261) was shown to bind specifically to the put control DNA (Fig. 1). To test whether the HTH motif was involved in DNA binding, the HTH domain was engineered and purified as PutA139258. PutA139258, however, failed to show DNA binding activity in gel mobility shift assays (Fig. 1). It was not clear whether the lack of DNA binding was caused by misfolding or by the inability of PutA139258 to form a dimer. Size-exclusion chromatography indicated PutA139258 purified as a polypeptide of molecular mass around 20 kDa. The predicted molecular mass of PutA139258 is 15.6 kDa, indicating that PutA139258 is a monomer. To further address the role of the HTH domain in DNA-binding, residues Arg-230 and Arg-234 were replaced with Ala in PutA669. The spacing of the two guanidinium residues and their apparent solvent accessibility implied that R230 and R234 would be involved in important ionic interactions with the DNA phosphodiester backbone and perhaps hydrogen bond pair interactions with specific nucleotide bases (13). Simultaneous removal of Arg-230 and Arg-234, however, did not disrupt the DNA binding activity of PutA669 (Fig. 1). PutA669 mutant R230A/R234A has similar PRODH activity and an FAD absorbance spectrum compared with wild-type PutA669 indicating proper folding of the PutA699 mutant. Thus, from the results with PutA139258 and PutA669 mutant R230A/R234A, it seemed unlikely that the putative HTH domain identified in the x-ray crystal structure of PutA669 was involved in DNA binding.
Attempts to locate the DNA-binding domain of PutA then focused on the N-terminal region of PutA. The role of the N-terminal region in PutA-DNA binding was first elucidated by engineering the N-terminal deletion mutant PutA 85. PutA 85 displays PRODH activity typical of PutA and has two main FAD absorbance bands at 452 and 377 nm in the UV-visible spectrum, with a 452/377 ratio of 1.13 that is slightly higher than PutA (1.05) (14). PutA 85 contains 0.8 mol of FAD/mol of polypeptide, similar to PutA (0.83 mol of FAD/subunit). Analysis of PutA 85 by size exclusion chromatography showed a single species with an estimated molecular mass of 128 kDa (data not shown). PutA 85 is composed of 1252 amino acids (including the C-terminal hexahistidine tag) and has a predicted molecular mass of 136,365 Da. Thus, PutA 85 purifies as a monomer in contrast to PutA, which purifies mainly as a dimer. PutA 85 was also shown to lack DNA-binding activity. PutA 85 was not observed to bind the put control DNA even at 100-fold molar excess of PutA 85 to DNA (data not shown). Therefore, the deletion of the N-terminal residues 185 has profound effects on dimerization and DNA-binding activity of PutA. Conclusions concerning the DNA binding domain, however, are not clear because PutA 85 does not purify as a dimer. The inability of PutA 85 to form a stable dimer may be the principal reason that PutA 85 lacks DNA-binding activity. Furthermore, the molecular dissection of PutA at amino acid codon 85 may divide a functional domain.
Characterization of PutA90 PutA90 was then designed to test the role of residues 185 in DNA binding. Fig. 1 shows that PutA90 binds to the put control DNA demonstrating that the DNA binding activity is at the N-terminal region of PutA. PutA90 was estimated to have a molecular mass of around 50 kDa, indicating PutA90 self-associates to a high molecular mass species during purification because the predicted molecular mass of PutA90 is only 9962 Da. The large estimated molecular mass of PutA90 suggests it contains residues involved in dimerization of PutA as initially observed with PutA
The ability of PutA90 to bind put control DNA and repress transcription in vivo was tested using -galactosidase reporter assays in the E. coli strain JT31 putA lacZ. The lacZ gene was positioned downstream of the put control DNA region in a low copy construct vector (pUTC03). Different truncated PutA proteins were encoded on a second plasmid (pUC18-PutA) to test transcriptional repressor activity. Wild-type PutA reduced -galactosidase activity to about 20% relative to control cells that lacked PutA protein. PutA669 and PutA90 repressed lacZ expression more strongly, with levels of -galactosidase activity diminished to <2% relative to controls cells. In contrast, PutA 85 reduced activity to only about 75% compared with control cells. Thus, the reporter assays demonstrate that PutA90 acts as a transcriptional repressor of the put control DNA in vivo. The greater repression of lacZ expression by PutA669 and PutA90 relative to PutA is most probably caused by interaction with the membrane, whereas PutA associates with both the DNA and the membrane (12). Partitioning of PutA onto the membrane would presumably relieve lacZ repression.
Assignment of an RHH MotifThe primary structure of PutA90 was then analyzed for any conserved DNA binding domains. A conserved domain architectural retrieval search identified an RHH domain of the CopG family in PutA residues 147. Fig. 3 shows the predicted secondary structure of PutA47 characterized by a
An alignment of selected PutA sequences with PutA47 is also shown in Fig. 3. PutA is known to have transcriptional repressor activity from Salmonella typhimurium, Klebsiella aerogenes, and Pseudomonas putida (7, 22, 23). In the remaining bacteria, such as Yersinia pestis, Ralstonia solanacearum, and Burkholderia fungorum, the regulation of the put regulon has not been described; based on the alignment in Fig. 3, however, PutA seems most likely to act as a transcriptional repressor as well. The inability to identify an RHH domain in PutA from other bacteria such as Bradyrhizobium japonicum and Sinorhizobium mellitus corroborates previous genetic studies with these microbes showing that PutA is not involved in transcriptional regulation of the put genes (24, 25). Thus, primary structure comparisons using PutA47 from E. coli should be valuable for identifying whether PutA from other organisms is endowed with DNA-binding activity. An interesting variation between PutA and the CopG family is the lack of the conserved Gly mediated turn between helix A and helix B. A Gly-mediated turn is conserved in RHH DNA-binding proteins, except for a few members such as MetJ. Based on the sequence alignment, Pro rather than Gly is predicted to direct the turn between helix A and B in PutA. Fig. 3 shows Pro-29 to be conserved in PutA from various bacteria. A classification of RHH proteins has recently been proposed on the basis of whether positively charged residues occur at the beginning (type I) or the end (type II) of the -strand (26). Therefore, Lys-10 is anticipated to reside toward the end of the -strand, classifying PutA as a type II RHH protein.
PutA47 was purified to test the prediction of the RHH motif in PutA. CD spectra of PutA and PutA47 are shown in Fig. 4. From the degree of ellipticity at 222 nm, the
Knowledge of the domain architecture of the PutA flavoprotein is necessary for understanding its unique multifunctional properties. After examination of a putative DNA-binding domain in residues 139258, our focus shifted to the N-terminal region of PutA. The N-terminal deletion mutant PutA 85 was shown to lack DNA-binding activity and to purify only as a monomer, suggesting the presence of a DNA-binding domain and a dimerization core in the N-terminal region of PutA. Subsequent characterization and conserved domain analysis of PutA90 suggested that an RHH DNA-binding domain was located in residues 147. In a RHH domain, a helix-helix hydrophobic dimerization core is formed while the -strands form an antiparallel -sheet that recognizes DNA. Our characterization of PutA47 clearly shows that residues 147 contain the entire DNA binding domain of PutA and are involved in stabilizing the dimeric structure of PutA. PutA47 binds specifically to the put control DNA region and acts as a transcriptional repressor in vivo. PutA47 also purifies as a dimer and has -helical content consistent with the RHH superfamily. Thus, even though PutA is a relatively large protein, the dimeric structure of PutA seems to primarily rely on a hydrophobic dimerization core analogous to members of the RHH family, which are considerably smaller proteins, such as the 53-residue Arc repressor (19). Members of the RHH family, such as the dimeric repressors MetJ, Arc, and CopG, exhibit cooperative DNA binding through dimer-dimer contacts on DNA (17, 27, 28). Mnt, a tetrameric repressor, also binds DNA cooperatively via dimer-dimer interactions (29). Formation of the PutA47-DNA complex seems to involve cooperativity consistent with properties of some RHH DNA-binding proteins (17, 29). In previous studies with PutA, cooperative DNA binding has not been described, although multiple PutA binding sites exist in the put control DNA (7, 12, 14). Detailed analysis of PutA-DNA interactions will be required to determine whether the observed cooperative DNA binding of PutA47 is relevant to the function of PutA as a transcriptional repressor or is unique to PutA47. Mapping of the PutA-DNA binding sites in the put control DNA region is in progress, which will help address cooperativity of PutA-DNA interactions. Coinciding with cooperative DNA binding, RHH members have been observed to cause DNA bending. In the x-ray crystal structure of the CopG-operator complex, the DNA is bent 60° when bound by the CopG tetramer (17). Likewise, PutA binding has been shown to induce significant curvature in the put control DNA (7). Thus, the cooperative DNA binding noted with PutA47 and the DNA bending observed with PutA are consistent with the DNA binding properties of the RHH family. As a result of our observations, we propose PutA is a member of the RHH family of transcriptional repressors, although definitive classification of PutA as an RHH member awaits structure determination. PutA would become the largest member of the RHH family of repressors with a unique appendage of an RHH motif on two large catalytic domains. Members of the RHH family are much smaller proteins, ranging from the 45-residue CopG repressor to the 133-residue NikR from E. coli, with variations caused by additional N- or C-terminal domains (17, 30). Examples of C-terminal functional regions in RHH members include protein tetramerization in the Mnt repressor, binding of the corepressor S-adenosylmethionine in MetJ, binding of the ParE toxin protein in the ParD repressor, and nickel binding by the repressor NikR (3136). In NikR, a C-terminal nickel-binding domain is attached to an N-terminal RHH fold (36). NikR regulates nickel uptake in bacteria by binding to promoter regions of the nik operon in the presence of excess nickel to repress transcription of genes nikABCDE (35). In the absence of nickel, NikR-DNA interactions are significantly weakened, allowing derepression of the nik operon (35). Activation of NikR DNA-binding has been proposed to involve nickel-dependent conformational changes that are propagated from the nickel regulatory domain to the RHH domain (36). PutA would join NikR, in which an RHH domain is affected by a regulatory site, but in the case of PutA, the regulation of DNA-binding involves FAD redox signaling. It seems that the RHH motif is quite adaptable to regulation by various sensory domains.
The discovery that the N-terminal region of PutA is responsible for DNA-binding activity and dimerization provides important new insights into the functional domain arrangement of PutA. The PRODH domain (residues 261612) has been clearly defined by x-ray crystallography, whereas the location of the P5C dehydrogenase domain (residues 6501130) is based on sequence analysis (13, 37). It is interesting that limited proteolysis of PutA by chymotrypsin generates two major polypeptide products that originate at Ser-58, demonstrating an accessible and flexible linker between the DNA-binding domain and the PRODH domain (11). The function of the region between the DNA-binding and the PRODH domains is not known, except that conformational changes have been mapped to residues in this region, specifically Ser-216Arg-234 (11). Therefore, this flexible region may be involved in transmitting signals from the PRODH active site to the DNA-binding domain that transform PutA from a DNA-binding protein to a membrane-bound enzyme. Models for how PutA switches from a DNA-binding protein to a peripheral position on the membrane generally involve proline reduction of FAD and a conformational change that increases the overall hydrophobicity of PutA and PutA-membrane associations (8, 10). Proline and FAD reduction only slightly affect the overall dissociation constant of the PutA-DNA complex (
* This work was supported in part by National Science Foundation Grant MCB0091664 and by National Institutes of Health grants GM61068 (to D. F. B.) and GM65546 (to J. J. T.), the University of Nebraska Biochemistry Department and Redox Biology Center, and the Nebraska Agricultural Research Division (Journal Series no. 14606). This publication was also made possible by National Institutes of Health Grant P20-RR-017675-02 from the National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| Current address: Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.
** Current address: Dept. of Anatomy and Neurobiology, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8108, St. Louis, MO 63110.
1 The abbreviations used are: P5C,
We thank Prof. Cynthia Dupureur (University of Missouri-St. Louis, St. Louis, MO) for help with the nitrocellulose binding assays.
This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||